electroCore to Participate at Upcoming Investor Conferences
Date: Tuesday, May 24, 2022
Webcast: H.C. Wainwright Webcast
Virtual Viewers: Livestream
Following the conferences, a webcast replay of the presentations will be available on the Investor section of the company’s website, electroCore.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.